Chemed Corp. (CHE)

440.47 -1.43%
12:26 pm EDT; Powered by Koyfin
Pros
Buy analyst rating
Average analyst stock price above current stock price
Cons
Revenue growth lower than the industry and sector averages
Forward P/E ratio high relative to industry peers
Forward P/B ratio high relative to industry peers
Forward PEG ratio high relative to industry peers
High short interest

Pros

  1. CHE average analyst rating is Strong Buy. See CHE analyst rating chart.
  2. CHE average analyst price target ($565.33) is above its current price ($436.56). See CHE price target chart.

Cons

  1. CHE quarterly revenue growth was -0.20%, lower than the industry and sector average revenue growth (9.66% and 6.06%, respectively). See CHE revenue growth chart.
  2. CHE forward P/E ratio is 21.37, which is high compared to its industry peers’ P/E ratios. See CHE forward P/E ratio chart.
  3. CHE Price/Book ratio is 9.46, which is high compared to its industry peers’ P/B ratios. See CHE forward Price/Book ratio chart.
  4. CHE PEG ratio (P/E adjusted for growth) is 3.30, which is high compared to its industry peers’ PEG ratios. See CHE PEG chart.
  5. CHE short interest (days to cover the shorts) ratio is 4.73. The stock garners more short interest than the average industry, sector or S&P 500 stock. See CHE short interest ratio chart.